The Latest Breaking News from Disease

5 Morning Habits That May Be Damaging Your Brain Slowly

Modern life has transformed mornings into a race against time. Millions of people wake up already stressed, immediately reach for their phones, skip breakfast, overload on caffeine, or rush through the start of the day without realizing how these habits may affect the brain over time. Neurologists and mental health…

MyLifeXP · May 13

Why Airflow Matters More Than You Think in Dense Gardens

Air doesn’t just move through a garden—it shapes it, protects it, and quietly decides which plants thrive and which struggle. Dense gardens often look lush and productive at first glance, but tight spacing can trap moisture, invite pests, and create hidden stress points for plants. Many gardeners focus heavily on…

Frugal Gardening · May 13

A New Study Warns That Women’s Blood Pressure Will Explode by 2050

Women’s heart health is facing a troubling future, according to a new scientific statement from the American Heart Association. Researchers now predict that nearly 60% of women in the United States could develop high blood pressure by 2050 if current trends continue. That sharp increase is raising alarms because high…

Budget and the Bees · May 13

ACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data Looms

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives said the company is focused on expanding its two commercial brands while preparing for several clinical data readouts in neuropsychiatric disorders, according to comments at the Bank of America Global Healthcare Conference. Chief Executive Officer Cat

MarketBeat · May 13

Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch

Axsome Therapeutics (NASDAQ:AXSM) executives said the company is preparing for a June launch of AUVELITY in Alzheimer’s disease agitation while continuing to expand its push in major depressive disorder, citing broad payer access, a larger sales force and what they described as a differentiated clin

MarketBeat · May 12

Capricor Therapeutics Q1 Earnings Call Highlights

Capricor Therapeutics (NASDAQ:CAPR) said its Duchenne muscular dystrophy therapy candidate deramiocel remains under active FDA review, while the company is preparing to commercialize the product itself amid a legal dispute with distribution partner NS Pharma and parent company Nippon Shinyaku. On t

MarketBeat · May 12

Your New Medical Problem: Where Are All These New Diseases Coming From?

With the latest outbreak of hantavirus on a cruise ship, many people have been left wondering where all these new diseases are coming from. After...

Saving Advice · May 12

Gabriel Carabello on the Best Hemodialysis Access: Cimino AV Fistula vs. Basilic Vein Transposition

Two of the most widely used surgical options are the Cimino arteriovenous (AV) fistula and the basilic vein transposition, each with distinct anatomical, functional, and long-term implications that influence patient outcomes.

International Business Times · May 12

Why the race to save these cherished penguins just became more urgent

The hoiho, also known as takaraka or yellow-eyed penguin, holds a special place in Aotearoa New Zealand’s natural identity.

The Conversation · May 12

Bilingualism and sex hormones may provide a new link to brain resilience and dementia risk

Why do some people maintain good memories and have healthy brains even as they age?

The Conversation · May 12